University of Manchester
133 articles about University of Manchester
-
Complement Therapeutics Ltd raises EUR 5 Million Seed Financing by BGV and Forbion and appoints Dr Rafiq Hasan as CEO
2/23/2022
Complement Therapeutics Ltd, a preclinical stage University of Manchester spinout, announced the completion of its EUR 5 million seed financing round from BioGeneration Ventures and Forbion, two leading European venture capital firms.
-
Agena Bioscience® and Manchester University Announce Partnership to Provide Educational Resources to the Pharmacogenomics Industry
11/29/2021
Agena Bioscience®, a global provider of genetic testing solutions, announced a partnership with Manchester University to expand awareness and access to PGx educational resources.
-
Together, the university and AVROBIO will look into an investigational lentiviral gene therapy for mucopolysaccharidosis type II (MPS II), or Hunter syndrome.
-
Firetinas, the First A.I. Thermal Scanner Against CoViD-19 the Corona Virus in China
3/20/2020
Firetinas, invented by a group of scholars from Cambridge University and Manchester University, had successfully helped China to control corona virus.
-
Top Contact Lens Experts Dispel Misinformation Regarding Coronavirus / COVID-19 Protections for Contact Lens Wearers
3/12/2020
Research scientists in Canada, United Kingdom and United States share guidance on safe wear and handling; thorough hand washing and disinfection compliance are important
-
“We have successfully engineered a new molecule, which is a modified sugar that shows broad-spectrum antiviral properties,” said Samuel Jones, from The University of Manchester.
-
Royal Manchester Children’s Hospital MPSIIIA patient receives world’s first gene therapy treatment for life-limiting genetic condition
5/24/2019
A two-year old patient at the Royal Manchester Children’s Hospital (RMCH) is the first in the world to receive a pioneering new ex vivogene therapy treatment using lentiviral vector-modified autologous stem cells for the rare and life-limiting genetic condition, Mucopolysaccharidosis IIIA (MPSIIIA).
-
University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development
3/7/2019
The University of Manchester, and Owlstone Medical announce the award of an Asthma UK/Innovate UK grant for theimprovement of asthma diagnosis.
-
Viagra and Cialis: PDE-5 Inhibitors May Have Broader Applications in Cancer, Neurology and Cardio...
11/13/2018
Viagra (sildenafil), Pfizer’s blockbuster drug for erectile dysfunction, is a classic example of how a drug developed for one thing can turn out to be successful for another. -
The Maui High-Performance Computing Center and the University of Manchester Join the OpenMP Effort
11/12/2018
33 vendors and research organizations now collaborating on developing standard parallel programming model
-
October 26 Research Roundup: New Cell Structures, Herpes and Alzheimer’s, Metformin Mechanism and...
10/26/2018
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them. -
Scientists Develop Counterfeit Booze-Detecting Device, University of Manchester Reveals
9/21/2017
-
Scientists Create World's First 'Molecular Robot' Capable Of Building Molecules, University of Manchester Study
9/21/2017
-
Dementia Breakthrough: Noninvasive Test Can Diagnose Alzheimer's, University of Manchester Reveals
9/6/2017
-
Miniaturised 'Heat Engines' Could Power Nanoscale Machines Of The Future, University of Manchester Study Reveals
5/15/2017
-
Smart Cane Could Transform Lives Of The Blind And Visually Impaired, University of Manchester Study
11/22/2016
-
Wet Weather And No Sun Really Does Make Chronic Pain Worse, University of Manchester Study
9/7/2016
-
Revolutionary Heart Attack Sensor Developed, University of Manchester Reveals
9/7/2016
-
Treatment Option For Alzheimer’s Disease Possible, University of Manchester Study
8/15/2016
-
University of Manchester And SCIEX Opened The £18 Million Stoller Biomarker Discovery Centre On June 14th
6/28/2016